CD4-directed Blocking Antibody
- Name
- CD4-directed Blocking Antibody
- Accession Number
- DBCAT005487
- Description
Not Available
- Drugs
Drug Drug Description Ibalizumab A CD4-specific antibody used to treat HIV infections. - Drugs & Drug Targets
Drug Target Type Ibalizumab T-cell surface glycoprotein CD4 target Ibalizumab C-C chemokine receptor type 5 target Ibalizumab C-X-C chemokine receptor type 4 target